BIOTON Company Description

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.

The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles.

BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland.

BIOTON S.A.

Country	Poland
Founded	1989
Industry	Pharmaceutical Preparations
Employees	364
CEO	Jeremy Launders

Contact Details

Address: ul. Poznanska 12 Ozarów Mazowiecki, 05-850 Poland
Phone	48 22 721 4000
Website	bioton.pl

Stock Details

Ticker Symbol	7U5
Exchange	Frankfurt Stock Exchange
Fiscal Year	January - December
Reporting Currency	PLN
SIC Code	2834

Key Executives

Name	Position
Jeremy Launders	Chief Executive Officer
Anna Grabowska	Chief Financial Officer
Michal Deptuch	Chief Operating Officer